These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37732867)

  • 41. Predictors of 'all-cause discontinuation' of initial oral antipsychotic medication in first episode psychosis.
    Mustafa S; Joober R; Lepage M; Iyer S; Shah J; Malla A
    Schizophr Res; 2018 Nov; 201():287-293. PubMed ID: 29706449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. You say "schizophrenia" and I say "psychosis": Just tell me when I can come off this medication.
    Zipursky RB; Odejayi G; Agid O; Remington G
    Schizophr Res; 2020 Nov; 225():39-46. PubMed ID: 32115315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protocol of guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis based on pragmatic design.
    Liu CC; Hsieh MH; Chien YL; Liu CM; Lin YT; Hwang TJ; Hwu HG
    Early Interv Psychiatry; 2022 Feb; 16(2):178-185. PubMed ID: 33751764
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol.
    Weller A; Gleeson J; Alvarez-Jimenez M; McGorry P; Nelson B; Allott K; Bendall S; Bartholomeusz C; Koval P; Harrigan S; O'Donoghue B; Fornito A; Pantelis C; Paul Amminger G; Ratheesh A; Polari A; Wood SJ; van der El K; Ellinghaus C; Gates J; O'Connell J; Mueller M; Wunderink L; Killackey E
    Early Interv Psychiatry; 2019 Dec; 13(6):1345-1356. PubMed ID: 30488637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis.
    Wils RS; Gotfredsen DR; Hjorthøj C; Austin SF; Albert N; Secher RG; Thorup AA; Mors O; Nordentoft M
    Schizophr Res; 2017 Apr; 182():42-48. PubMed ID: 28277310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Specialised first-episode psychosis services: a systematic review of the literature].
    Skalli L; Nicole L
    Encephale; 2011 May; 37 Suppl 1():S66-76. PubMed ID: 21600336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting 1-year risk for relapse in patients who have discontinued or continued quetiapine after remission from first-episode psychosis.
    Hui CL; Wong GH; Tang JY; Chang WC; Chan SK; Lee EH; Lam MM; Chiu CP; Law CW; Chung DW; Tso S; Pang EP; Chan KT; Wong YC; Mo FY; Chan KP; Hung SF; Honer WG; Chen EY
    Schizophr Res; 2013 Oct; 150(1):297-302. PubMed ID: 23993865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Second-generation antipsychotic discontinuation in first episode psychosis: an updated review.
    Miller BJ; Bodenheimer C; Crittenden K
    Clin Psychopharmacol Neurosci; 2011 Aug; 9(2):45-53. PubMed ID: 23429653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design.
    Devanand DP; Mintzer J; Schultz S; Sultzer D; de la Pena D; Gupta S; Colon S; Schimming C; Pelton GH; Andrews H; Levin B
    Am J Geriatr Psychiatry; 2012 Apr; 20(4):362-73. PubMed ID: 21407047
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antipsychotic dose reduction compared to dose continuation for people with schizophrenia.
    Rodolico A; Siafis S; Bighelli I; Samara MT; Hansen WP; Salomone S; Aguglia E; Cutrufelli P; Bauer I; Baeckers L; Leucht S
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD014384. PubMed ID: 36420692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction).
    Moncrieff J; Lewis G; Freemantle N; Johnson S; Barnes TRE; Morant N; Pinfold V; Hunter R; Kent LJ; Smith R; Darton K; Horne R; Crellin NE; Cooper RE; Marston L; Priebe S
    BMJ Open; 2019 Nov; 9(11):e030912. PubMed ID: 31780589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach.
    Glick ID; Correll CU; Altamura AC; Marder SR; Csernansky JG; Weiden PJ; Leucht S; Davis JM
    J Clin Psychiatry; 2011 Dec; 72(12):1616-27. PubMed ID: 22244023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment Discontinuation Impact on Long-Term (10-Year) Weight Gain and Lipid Metabolism in First-Episode Psychosis: Results From the PAFIP-10 Cohort.
    Vázquez-Bourgon J; Mayoral-van Son J; Gómez-Revuelta M; Juncal-Ruiz M; Ortiz-García de la Foz V; Tordesillas-Gutiérrez D; Ayesa-Arriola R; Bioque M; Crespo-Facorro B
    Int J Neuropsychopharmacol; 2021 Jan; 24(1):1-7. PubMed ID: 32840607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis.
    Alvarez-Jiménez M; Parker AG; Hetrick SE; McGorry PD; Gleeson JF
    Schizophr Bull; 2011 May; 37(3):619-30. PubMed ID: 19900962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of LAI in first episode psychosis: an observational study--clinical reports.
    Cervone A; D'Onghia A; Ferrara M; Massaro CR
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S348-52. PubMed ID: 26417794
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-acting injectable second-generation antipsychotics in first-episode psychosis: a narrative review.
    Salgueiro M; Segarra R
    Int Clin Psychopharmacol; 2019 Mar; 34(2):51-56. PubMed ID: 30540617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment.
    Farahani A; Correll CU
    J Clin Psychiatry; 2012 Apr; 73(4):486-96. PubMed ID: 22579147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
    Dold M; Samara MT; Li C; Tardy M; Leucht S
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.